Our Focus
We specialise exclusively in the intellectual property challenges surrounding biologics, biosimilars, and advanced protein-based therapeutics, helping innovators secure market advantage across rapidly evolving scientific and regulatory landscapes.
How We Support Your Innovation
1.High-Value Biologics IP Protection
Safeguard your innovations with strategies built for complex biologic modalities.
Our experience includes:
- Patents covering novel biologic molecules such as antibodies, peptides, aptamers, and nucleic acid therapeutics
- Protection for antibody–drug conjugates (ADCs), biologic delivery systems, and next-generation therapeutic platforms
- Capturing and defending critical market share through robust, commercially aligned patent portfolios
2. Biosimilar Strategy & Post-Grant Expertise
Navigate competitive landscapes with confidence.
-
Significant experience in multi-party oppositions and post-grant proceedings involving major biologics
-
Strategic defence and enforcement to protect revenue and delay biosimilar entry
-
Insight into global patent trends shaping biosimilar challenges and opportunities
3. Protein Manufacturing & Process IP
Comprehensive coverage across the entire biologics manufacturing lifecycle.
-
Strong understanding of IP surrounding monoclonal antibody production
-
Expertise across cell culture, upstream and downstream processing, and analytical & QC technologies
-
Guidance that aligns scientific realities with legally defensible protection
Why Secerna
-
Specialists with deep technical backgrounds in molecular biology, biochemistry, protein engineering, and related fields
-
Proven track record supporting clients through complex, high-stakes biologics disputes
-
Strategic, commercially driven patenting that withstands scrutiny in fast-moving markets
Your innovation deserves the highest level of IP protection. Let’s explore how our team can strengthen your position and accelerate your path to market.
Book Your Complimentary 1-Hour Consultation
Discover how Secerna can tailor its biologics and biosimilars expertise to your unique scientific and commercial challenges.